TLDR Tilray Brands (TLRY) stock drops 3.36% to $3.59 despite strong quarterly revenue. Tilray’s Q1 revenue jumps 23% to $257.1M, while net losses reach $40 million. Beverage revenue surges 82
Tilray Brands (TLRY) stock fell 3.36% to $3.59 at Thursday’s close, despite reporting strong quarterly revenue growth. Shares later recovered 0.61% to $3.6120 in after-hours trading on October 8. The company reported a $40 million first-quarter net loss, while revenue increased 23% year-over-year.
Tilray reported record first-quarter revenue of $257.1 million for the period ending August 31, 2026. Revenue increased from $209.5 million during the same quarter last year. Meanwhile, gross profit climbed 35% to $77.5 million, supported by improvements across several business segments.
The company’s gross margin expanded from 27% to 30%, reflecting stronger profitability across its operations. Tilray recorded a net loss of $40 million, largely due to noncash charges. The company reported a loss of $0.32 per share, while adjusted losses totaled $3 million.
Adjusted earnings per share showed a loss of $0.02 during the quarter. Furthermore, adjusted EBITDA declined to $9.2 million from $10.2 million a year earlier. Management attributed part of the decline to approximately $1.7 million in global fuel surcharges.
Tilray’s beverage business generated $101.5 million in revenue, representing an 82% annual increase. The acquisition of BrewDog contributed to this growth and expanded the company’s beverage operations. Beverage gross profit nearly doubled to $42 million, while margins improved from 38% to 41%.
Cannabis revenue declined to $56.1 million from $64.5 million in the previous year. Cannabis gross profit also slipped to $22 million, compared with $23.3 million previously. Despite lower sales, the segment improved its gross margin to 39% from 36%.
Distribution revenue increased 14% to $84.3 million, supported by the company’s pharmaceutical distribution operations. Wellness revenue remained near $15.3 million, although gross profit declined to $4.4 million. These results highlighted differences in performance across Tilray’s cannabis, beverage, distribution, and wellness businesses.
Tilray ended the quarter with $221.4 million in cash, restricted cash, and marketable securities. The company also reduced outstanding debt by $42 million during the fiscal year. These measures strengthened its financial position while management continued integrating recently acquired operations.
For fiscal 2027, Tilray reaffirmed its adjusted EBITDA forecast of $68 million to $75 million. The company expects stronger financial performance during the second half of its fiscal year. Management also expects the fourth quarter to contribute significantly to annual results.
Tilray continues expanding its presence across cannabis, beverages, wellness, and pharmaceutical distribution markets. Its agreement with Carlsberg will introduce production and sales of selected beer brands in the United States. The partnership will begin January 1, 2027, extending Tilray’s beverage operations beyond its existing portfolio.
The post Tilray Brands (TLRY) Stock: Drops as Q1 Net Loss Hits $40M and Revenue Jumps 23% appeared first on Blockonomi.
